Amantadine and other antiglutamate agents: management of Parkinson's disease.
D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D011597:Psychomotor Performance / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic
D000978:Antiparkinson Agents; D018698:Glutamic Acid; D000547:Amantadine